🇺🇸 FDA
Company

Bolt

Bolt Biotherapeutics

BOLT pharma USA

Quick answer

Bolt is a pharma company (BOLT) headquartered in REDWOOD CITY, CA, USA with 4 tracked pipeline programs.

Pipeline (4)

project

BDC-1001

HER2-positive Solid Tumors

Phase 2 · small_molecule · terminated

1 trials project

BDC-1001

Metastatic Breast Cancer

Phase 2 · small_molecule · terminated

1 trials project

BDC-4182

Gastric Cancer Adenocarcinoma Metastatic

Phase 2 · small_molecule · active

1 trials project

BDC-3042

Triple Negative Breast Cancer

Phase 1 · small_molecule · terminated

1 trials

Patents (7)

patent

US 12325750

Anti-Dectin-2 antibodies and methods of using

Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11753474

Anti-Dectin-2 antibodies

Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11654199

Thienoazepine immunoconjugates, and uses thereof

Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11547761

Antibody adjuvant conjugates

Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11400164

Immunoconjugates targeting HER2

Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11110178

Antibody adjuvant conjugates

Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10675358

Antibody adjuvant conjugates

Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)